Comment on "Switching to Subcutaneous Infliximab Maintenance Therapy is Effective in Patients with Inflammatory Bowel Disease"
PMID: 40551056
Source: Dig Dis Sci
Publication date:
2025-07-24
Year:
2025
Abstract
NULL